NumFin

Myriad Genetics, Inc.

Sembol: MYGN

NASDAQ

21.6

USD

Bugünkü piyasa fiyatı

  • -7.5210

    F/K Oranı

  • -0.4011

    PEG Oranı

  • 1.94B

    MRK Kapağı

  • 0.00%

    DIV Verimi

Myriad Genetics, Inc. (MYGN) Finansal Tablolar

Download
YıllıkÜç Aylık
DoğrusalGünlük
Grafikte için dinamiklerde varsayılan sayıları görebilirsiniz Myriad Genetics, Inc. (MYGN). Şirketin geliri NaN M ortalamasını gösterir ki bu da NaN % gowth'dur. Tüm dönem için ortalama brüt kar NaN M olup NaN % dir. Ortalama brüt kar oranı NaN %dır. Şirketin geçen yılki performansı için net gelir artışı NaN % olup NaN % %'ne eşittir. tüm şirket geçmişi için ortalama.,

YıllıkÜç Aylık
10Y20Y30Y40Y

Bilanço

Myriad Genetics, Inc.'nın mali yörüngesine baktığımızda, ortalama bir varlık büyümesi gözlemliyoruz. Bu oran, ilginç bir şekilde, şirketin hem en yüksek hem de en düşük seviyelerini yansıtarak olarak gerçekleşiyor. Çeyrekten çeyreğe karşılaştırıldığında, bu rakam olarak ayarlanmaktadır. Geçtiğimiz yıla bakıldığında toplam varlık değişiminin NaN olduğu görülür. Toplam özkaynak ile gösterilen hissedar değeri, raporlama para biriminde NaN olarak değerlenir. Bu açıdan yıldan yıla değişim NaN%'dir.

common:word.in-mln

USD
Growth
TTM202220212019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

balance-sheet.row.cash-and-short-term-investments

0114.9339.8136.9
136.9
180.6
150.7
159
144.8
270.6
531.1
454.2
346.5
403.2
316.9
328.7
308.3
227.7
113.8
115.4
72.8
73.1
127.2
80.5
9.9
14.6
15.7
13.2

balance-sheet.row.short-term-investments

05881.443.7
43.7
69.7
48.3
90.5
80.7
121.6
268.2
254.2
293.8
310.4
253.3
91
164.9
129.2
64.3
31.4
11.2
12
91.3
24.3
4.5
0
0
0

balance-sheet.row.net-receivables

0101.691.3138.6
138.6
102.1
111.3
95
87.7
98.7
97.7
63.1
50.3
48.1
45.3
45.4
32.5
22.2
18.4
14.5
22.3
7.5
5.8
2.8
3.2
0.6
0.5
0

balance-sheet.row.inventory

020.115.331.4
31.4
34.3
42.2
38.3
25.1
23.9
5
11.6
5.7
-399.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-current-assets

020.438.441.7
46.4
9.4
12.9
22.2
26
27
9
7.3
417.9
488.4
4
3.1
2.5
2.3
3.3
7.3
7.7
4.8
4.2
2.7
0.6
16.5
32.4
37.4

balance-sheet.row.total-current-assets

0274.6484.8348.6
348.6
326.4
317.1
314.5
283.6
400.1
634.7
530.6
479.3
540.6
366.2
377.3
343.3
252.3
135.6
137.2
102.8
85.4
137.2
85.9
13.7
31.7
48.6
50.6

balance-sheet.row.property-plant-equipment-net

0187.3125.357.3
57.3
43.2
51.1
58.3
67.2
34.6
27.6
24.2
23.1
23.3
22.6
30
24.9
19.8
18.5
17.3
18.7
15.4
12.7
11.3
10
12.4
12
9.4

balance-sheet.row.goodwill

0286.8239.2417.2
417.2
318.6
316.1
195.3
177.2
169.2
56.9
56.9
56.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0379.7404.1684.7
684.7
455.2
491.6
227.5
192.6
205.3
13.3
15.7
16.7
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0666.5643.31101.9
1101.9
773.8
807.7
422.8
369.8
374.5
70.2
72.6
72.8
-85.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-investments

054.85954.9
54.9
30.7
48.5
79.9
40.6
84.1
158.7
113.7
70.9
85.2
75.4
91.3
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

0000
0
0
0
0
0
9.6
36.6
36.2
35.7
28
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

015.58.30
-1214.1
0
0
5
5
-79.1
-124.1
-86.7
-70.9
2.1
2.3
0.7
3.9
4.5
4.9
33.8
61.3
56.6
22.2
9.2
29.9
23.3
15.5
19.6

balance-sheet.row.total-non-current-assets

0924.1835.91214.1
1214.1
847.7
907.3
566
482.6
423.7
169.1
160
131.5
53.3
100.3
122
28.8
24.3
23.4
51.2
80
72
34.9
20.4
39.9
35.7
27.5
29

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

01198.71320.71562.7
1562.7
1174.1
1224.4
880.5
766.2
823.8
803.8
690.6
610.8
593.8
466.4
499.3
372.1
276.6
159
188.4
182.8
157.4
172.1
106.4
53.6
67.4
76.1
79.6

balance-sheet.row.account-payables

028.829.633.3
33.3
26
22
21.1
21.1
23.1
18.1
10.1
11.4
8.9
14.2
24.9
15.8
11.8
11.9
7.9
11.5
9.5
9.7
4.3
2.9
5.1
2.6
2.2

balance-sheet.row.short-term-debt

014.11378.9
78.9
68.3
65.6
0
0
0
0
0
9.6
0
0
0
0
0
0
0
0
3.6
0
0
0
0.1
0.3
0.3

balance-sheet.row.tax-payables

04.843
3
4.3
7.1
2.8
3.8
277.9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

0130.979.3233.5
233.5
9.3
99.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.5

Deferred Revenue Non Current

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

093.7156.53.4
82.3
5.3
127.3
49.5
46.1
56.4
44.3
32.8
21.6
27.4
18
46.8
15.6
14.9
10.1
5.9
4.9
1
3.1
24.4
2.4
4.7
6.9
6.5

balance-sheet.row.total-non-current-liabilities

0175.7148.6356
356
107
229.1
60.1
35.4
24.2
10.7
10
9.6
8.8
14.2
26.9
16.1
11.9
13.1
9.1
14.4
23.9
29.5
4.3
0.1
5.2
0.1
0.4

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
-9.6
-8.8
-14.2
-26.9
-16.1
-11.9
-13.1
-9.1
-14.4
-23.9
-29.5
-4.3
0
-5.2
0
0

balance-sheet.row.capital-lease-obligations

014592.370.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0312.9352.9473.8
473.8
209.2
446.6
132.4
104.1
104.8
75.2
55
44
36.3
32.2
73.7
31.7
26.8
23.3
15.1
19.3
28.5
32.6
28.7
5.4
9.9
9.9
9.4

balance-sheet.row.preferred-stock

0000
5.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

00.80.80.7
0.7
0.7
0.7
0.7
0.7
0.7
0.8
0.8
0.9
0.9
1
0.4
0.4
0.4
0.3
0.3
0.3
0.2
0.2
0.2
0.1
0
0
0

balance-sheet.row.retained-earnings

0-366.2-254.225.6
25.6
52.8
-68.4
-73.2
-77
2
30.9
-12.7
-38.6
-10.5
-119.9
-204.6
-252.4
-217.4
-179.2
-139.3
-98.7
-73.8
-59.8
-52.7
-43.9
-33.9
-24.1
-14.9

balance-sheet.row.accumulated-other-comprehensive-income-loss

0-8.9-5.1-5.4
-5.4
-4
-5.5
-9.5
-7
-1.5
-0.4
-0.2
0.2
0.1
2.8
-0.2
-0.4
-0.7
-0.5
-0.2
0.7
0.3
0.4
-0.1
-0.3
0
0
0

balance-sheet.row.other-total-stockholders-equity

01260.11226.31068
1068
915.4
851.4
830.1
745.4
717.8
697.3
647.7
604.4
567
550.4
630
592.7
467.6
315.1
312.5
261.2
202.1
198.8
130.2
92.3
91.4
90.3
85.1

balance-sheet.row.total-stockholders-equity

0885.8967.81088.9
1088.9
964.9
778.2
748.1
662.1
719
728.6
635.7
566.8
557.6
434.2
425.7
340.4
249.8
135.7
173.3
163.5
128.9
139.6
77.7
48.2
57.5
66.2
70.2

balance-sheet.row.total-liabilities-and-stockholders-equity

01198.71320.71562.7
1562.7
1174.1
1224.4
880.5
766.2
823.8
803.8
690.6
610.8
593.8
466.4
499.3
372.1
276.6
159
188.4
182.8
157.4
172.1
106.4
53.6
67.4
76.1
79.6

balance-sheet.row.minority-interest

0000
0
0
-0.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

0---
1088.9
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0112.8140.498.6
98.6
100.4
96.8
170.4
121.3
205.8
427
367.9
364.6
395.5
328.7
182.3
164.9
129.2
64.3
31.4
11.2
12
91.3
24.3
4.5
0
0
0

balance-sheet.row.total-debt

014592.3233.5
233.5
9.3
99.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.1
0.4
0.8

balance-sheet.row.net-debt

088.1-166.1140.3
140.3
-101.6
-3.3
-68.5
-64.1
-64.8
-104.1
-86.4
-52.7
-92.8
-63.5
-237.7
-143.4
-98.6
-49.5
-84
-61.6
-61.1
-35.9
-56.2
-5.4
-14.5
-15.3
-12.4

Nakit Akış Tablosu

Myriad Genetics, Inc.'nın mali durumu son dönemde serbest nakit akışında kayda değer bir değişim göstererek NaN şeklinde bir değişim sergilemiştir. Şirket kısa süre önce NaN ihraç ederek sermayesini artırmış ve bir önceki yıla kıyasla NaN oranında bir farka işaret etmiştir. Şirketin yatırım faaliyetleri, raporlama para birimi cinsinden NaN tutarında net nakit kullanımıyla sonuçlanmıştır. Bu, bir önceki yıla göre NaN değişimidir. Aynı dönemde şirket, şirketin yatırım ve geri ödeme stratejilerini anlamada önemli olan NaN, NaN ve NaN 'i kaydetti. Şirketin finansman faaliyetleri NaN net nakit kullanımına yol açmış ve bir önceki yıla göre NaN farkı oluşmuştur. Ayrıca, şirket hissedarlarına temettü ödemeleri için NaN ayırmıştır. Aynı zamanda, NaN olarak adlandırılan ve bu dönemde nakit akışını önemli ölçüde etkileyen başka finansal manevralar da yapmıştır. Bu bileşenler birlikte ele alındığında, şirketin finansal durumu ve nakit akışı yönetimine yönelik stratejik yaklaşımı hakkında kapsamlı bir resim çizmektedir.

common:word.in-mln

USD
Growth
TTM202220212019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

cash-flows.row.net-income

0-112-27.24.6
4.6
131
21.8
125.3
80.2
176.2
147.1
112.2
100.7
152.3
84.6
47.8
-35
-38.2
-40
-40.6
-24.8
-14
-7.2
-8.7
-10
-9.8
-9.2
-5.9

cash-flows.row.depreciation-and-amortization

052.762.873
73
54.4
48.3
26.7
25
13.8
8.9
9.1
7.2
7.1
9.4
8.8
7.5
6.9
6.1
5.8
5.3
4.5
3.7
3.3
3.2
3.3
2.5
1.6

cash-flows.row.deferred-income-tax

0-31.9-34.713.1
13.1
-23.7
2.5
15.7
1.7
7.5
8.2
34.2
40.4
-28.1
0.5
0
0
0.2
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

038.136.333.5
33.5
27.1
29.9
31.6
45.7
27.1
26.6
26.3
25.1
22.8
25.7
0
0
-0.2
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-101.5120.4-37.1
-37.1
-21.6
-36.6
-65.4
-40.7
-60
-41
-28.8
38.5
-27.4
-54.1
16.9
-11.2
-1.4
6.1
1.9
-27.3
-7.3
-0.7
22.1
-7.5
-0.6
-0.1
5.6

cash-flows.row.account-receivables

0-10.3-8.8-18.2
-18.2
-39.2
-41.4
-39.2
-34.4
-24.4
-67.2
-34.9
-15
-21.7
-19.9
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-2.91.68
8
7.9
-1.2
-14.6
-0.8
-15.8
6.6
-3.4
0.2
-0.5
-21.5
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.account-payables

0-3.59.21.1
1.1
4
-3
-11.4
-3.1
-1.5
8
-1.2
0.3
-5.3
-10.7
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-84.8118.4-28
-28
5.7
9
-0.2
-2.4
-18.3
11.6
10.9
53
0
-2
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-non-cash-items

048.3-139.4-3.4
-3.4
-51.3
40.3
32.4
28.6
25.6
24.1
-11.1
-81.2
28.4
17.9
30.3
12.7
4.7
4.5
2
0.4
0.5
0.4
0.5
0.2
0.1
0.2
0.1

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-45.3-18-8.6
-8.6
-8.4
-6.1
-5
-23.9
-14.3
-11.4
-10.2
-5.8
0
-7.5
-13.7
-11.4
-7.7
-6.7
-3.9
-8
-6.9
-5.3
-4.6
-4
-3.2
-4.7
-6.4

cash-flows.row.acquisitions-net

0-57.2379.1-278.5
-278.5
8.4
-216.1
-37
-20.1
-223.5
-5
-0.8
-79.4
0
7.5
0
0
0
0
0
0
0
0
0
0
0
0.1
0

cash-flows.row.purchases-of-investments

0-103.2-147.8-78.5
-78.5
-80.9
-87.5
-164.5
-80.7
-161.8
-443.8
-396.1
-425.2
-477.6
-308.6
-191.7
-197.8
-165.5
-44.6
-52.7
-51.8
-89.8
-249.3
-24
-291.7
-840.6
-582.8
-622.2

cash-flows.row.sales-maturities-of-investments

0128.261.179.2
79.2
77.7
163.4
115.1
165.6
381.9
384.6
385.2
456.1
52.2
111.8
174.4
162.5
100.5
71
58.6
50.7
137.2
172.2
25
300.2
841.1
592.2
569.6

cash-flows.row.other-investing-activites

0000
0
-8.4
0
0
0
0
0
-17.1
-0.1
348.7
-9.6
-0.3
0
-0.1
-0.1
-0.1
-2.9
-2.5
-2.7
-0.8
0
0
-0.1
0

cash-flows.row.net-cash-used-for-investing-activites

0-77.5274.4-286.4
-286.4
-11.6
-146.3
-91.4
40.9
-17.7
-75.6
-38.9
-54.4
-76.7
-206.3
-31.3
-46.7
-72.8
19.5
1.9
-12
38.1
-85.1
-4.3
4.5
-2.7
4.7
-59

cash-flows.row.debt-repayment

00-226.4-115
-115
-143
-305
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

06.391.88.7
8.7
36.9
6
0
30
0
0
0
25.1
22.3
84.2
21.9
117.5
149.9
2.5
51.3
59
3.4
68.6
38
0.6
0.6
4.6
59.2

cash-flows.row.common-stock-repurchased

000-50
-50
0
-31.6
-162.6
-210.7
-287.7
-146.3
-128.5
-200.5
-71.4
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

000-340
-340
0
-403
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

0-14.3-16678.6
338.6
11.1
805.4
94.3
3.4
75.9
65.7
59.2
58.8
0
-136.1
0
0
0
0
0
0
0
0
0
-0.2
-0.4
-0.3
-0.3

cash-flows.row.net-cash-used-provided-by-financing-activities

0-8-150.6182.3
182.3
-95
71.8
-68.3
-177.3
-211.8
-80.6
-69.2
-116.6
-49.1
-51.9
21.9
117.5
149.9
2.5
51.3
59
3.4
68.6
38
0.4
0.2
4.3
58.9

cash-flows.row.effect-of-forex-changes-on-cash

0-0.6-0.62.7
2.7
-0.8
2.2
-2.2
-4.8
0
0
0
0.1
0
0
0
0
0
0
0
0
0
0
0
0
-14.6
-15.6
-13.2

cash-flows.row.net-change-in-cash

0-192.4141.4-17.7
-17.7
8.5
33.9
4.4
-0.7
-39.3
17.7
33.7
-40.2
29.3
-174.2
94.3
44.9
49.1
-1.3
22.4
0.5
25.1
-20.3
50.8
-9.2
-24.1
-13.2
-11.9

cash-flows.row.cash-at-end-of-period

066.4258.493.2
93.2
110.9
102.4
68.5
64.1
64.8
104.1
86.4
52.7
92.8
63.5
237.7
143.4
98.6
49.5
84
61.6
61.1
35.9
56.2
5.4
0
0
0

cash-flows.row.cash-at-beginning-of-period

0258.8117110.9
110.9
102.4
68.5
64.1
64.8
104.1
86.4
52.7
92.8
63.5
237.7
143.4
98.6
49.5
50.8
61.6
61.1
35.9
56.2
5.4
14.6
24.1
13.2
11.9

cash-flows.row.operating-cash-flow

0-106.318.283.7
83.7
115.9
106.2
166.3
140.5
190.2
173.9
141.8
130.8
155.1
84
103.7
-25.9
-28
-23.3
-30.9
-46.5
-16.3
-3.8
17.2
-14.1
-7
-6.6
1.4

cash-flows.row.capital-expenditure

0-45.3-18-8.6
-8.6
-8.4
-6.1
-5
-23.9
-14.3
-11.4
-10.2
-5.8
0
-7.5
-13.7
-11.4
-7.7
-6.7
-3.9
-8
-6.9
-5.3
-4.6
-4
-3.2
-4.7
-6.4

cash-flows.row.free-cash-flow

0-151.60.275.1
75.1
107.5
100.1
161.3
116.6
175.9
162.5
131.7
125
155.1
76.5
90.1
-37.3
-35.7
-30
-34.8
-54.6
-23.2
-9
12.5
-18.1
-10.2
-11.3
-5

Gelir Tablosu Satırı

Myriad Genetics, Inc.'nın geliri bir önceki döneme göre NaN% oranında bir değişim gösterdi. Şirketin MYGN brüt kârı NaN olarak raporlanmıştır. Şirketin işletme giderleri NaN olup, geçen yıla göre NaN% değişim göstermiştir. Amortisman ve itfa giderleri NaN, yani NaN% son hesap dönemine göre değişimdir. İşletme giderleri NaN olarak raporlanmıştır ve yıldan yıla NaN% değişim göstermektedir. Satış ve pazarlama giderleri NaN, bir önceki yıla göre NaN% değişimdir. Son rakamlara göre FAVÖK NaN olup, yıldan yıla NaN% büyümeyi temsil etmektedir. Faaliyet geliri NaN olup, bir önceki yıla göre NaN% değişim göstermektedir. Net gelirdeki değişim NaN%'dir. Geçen yılın net geliri NaN idi.

common:word.in-mln

USD
Growth
TTM202220212019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995

income-statement-row.row.total-revenue

0678.4690.6851.1
851.1
772.6
771.4
753.8
723.1
778.2
613.2
496
402.1
362.6
326.5
333.6
157.1
114.3
82.4
56.6
64.3
53.8
45.2
34
25.3
23.2
15.2
6.6

income-statement-row.row.cost-of-revenue

0202197.6201
201
177.2
171.2
157.3
147.4
109.2
79.6
64.7
46.7
44.3
43.3
32.3
30.8
27.6
20.3
13.8
12.6
10.7
7.4
0.7
-0.1
-1.9
-2.2
-1.6

income-statement-row.row.gross-profit

0476.4493650.1
650.1
595.4
600.2
596.5
575.7
669
533.5
431.3
355.4
318.4
283.3
301.3
126.3
86.6
62.1
42.9
51.8
43.1
37.8
33.3
25.4
25.1
17.4
8.2

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

00.6139.31.2
1.2
-0.4
-2.5
1.2
0.3
-2
-0.2
-0.4
0
0
0
0
0
0
0
0
0
0
0
3.3
3.2
3.3
2.5
1.6

income-statement-row.row.operating-expenses

0600.1681.7641.4
641.4
537.9
550.8
429.7
441.5
394.6
305.5
251
197.6
183.3
156.8
263.2
174
132.2
102.8
85.5
79.1
61.8
50.9
44.9
37.8
38.1
29.9
17.1

income-statement-row.row.cost-and-expenses

0802.1879.3842.4
842.4
715.1
722
587
588.9
503.8
385.2
315.7
244.3
227.6
200.1
295.5
204.9
159.9
123.2
99.3
91.7
72.5
58.3
45.6
37.7
36.2
27.7
15.5

income-statement-row.row.interest-income

02.60.73.2
3.2
1.8
1.2
0.9
0.4
5.4
5.5
4.6
2.2
5.7
12.5
13.7
12.1
7.4
2.8
0
2.9
5.4
0
0
0
0
0
0

income-statement-row.row.interest-expense

03.26.612
12
3.2
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-16.9-8.40.1
0.1
60.8
-1.7
1.2
0.3
-2
-0.2
-0.4
-0.4
0.1
-2.5
-3.3
0.7
0
-2
0
0
-0.2
-0.3
-0.4
12.4
3.2
3.3
3.1

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

00.6139.31.2
1.2
-0.4
-2.5
1.2
0.3
-2
-0.2
-0.4
0
0
0
0
0
0
0
0
0
0
0
3.3
3.2
3.3
2.5
1.6

income-statement-row.row.total-operating-expenses

0-16.9-8.40.1
0.1
60.8
-1.7
1.2
0.3
-2
-0.2
-0.4
-0.4
0.1
-2.5
-3.3
0.7
0
-2
0
0
-0.2
-0.3
-0.4
12.4
3.2
3.3
3.1

income-statement-row.row.interest-expense

03.26.612
12
3.2
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

055.962.873
73
54.4
48.3
26.7
25
13.8
8.9
9.1
7.2
7.1
9.4
8.8
7.5
6.9
6.1
5.8
5.3
4.5
3.7
3.3
3.2
3.3
2.5
1.6

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-123.7-48.77.6
7.6
118.7
49.4
166.8
134.2
274.4
228
180.3
157.8
135.1
126.5
38.1
-47.7
-45.6
-40.7
-42.6
-27.3
-18.7
-13.1
-11.5
-12.4
-13
-12.5
-8.9

income-statement-row.row.income-before-tax

0-140.6-57.10.2
7.7
116.9
42.9
168.9
134.9
277.9
233.3
184.5
159.7
140.8
136.4
48.5
-35
-38.2
-40
-40.6
-24.4
-13.5
-6.6
-8.7
-10
-9.8
-9.2
-5.9

income-statement-row.row.income-tax-expense

0-28.6-29.9-4.4
-4.4
-13.9
21.3
43.6
54.7
101.6
86.1
72.4
58.9
-11.5
0.2
0.6
35
-7.4
-0.8
-2
0.4
0.5
0.6
8.7
10
9.8
9.2
5.9

income-statement-row.row.net-income

0-112-27.24.6
4.6
131
21.8
125.3
80.2
176.2
147.1
112.2
100.7
152.3
84.6
47.8
-35
-38.2
-40
-40.6
-24.8
-14
-7.2
-8.7
-10
-9.8
-9.2
-5.9
Benzer Hisse Senetleri
Bunlar da ilginizi çekebilir:
THYROCARE.BO
Thyrocare Technologies Limited.
605.85 INR
BSE
HTGM
HTG Molecular Diagnostics, Inc..
0.48 USD
NASDAQ
CO
Global Cord Blood Corporation.
2.9876 USD
NYSE
ANPCF
ANGLE plc.
0.16678 USD
PNK
DIUXF
Diaceutics PLC.
1.3672 USD
PNK
CNTG
Centogene N.V..
0.71 USD
NASDAQ
DMTK
DermTech, Inc..
0.6906 USD
NASDAQ
HTGMQ
HTG Molecular Diagnostics, Inc..
0.0015 USD
PNK
SQIDF
SQI Diagnostics Inc..
0.0149 USD
PNK

Sıkça Sorulan Sorular

Nedir Myriad Genetics, Inc. (MYGN) toplam varlıklar?

Myriad Genetics, Inc. (MYGN) toplam varlıklar 1198700000.000 şeklindedir.

İşletmenin yıllık geliri nedir?

Yıllık gelir N/A'dur.

Firma kâr marjı nedir?

Firma kar marjı 0.689'dir.

Şirket serbest nakit akışı nedir?

Serbest nakit akışı -1.692'dur.

İşletme net kar marjı nedir?

Net kâr marjı -0.374'dir.

Firma toplam geliri nedir?

Toplam gelir -0.370'dur.

Nedir Myriad Genetics, Inc. (MYGN) net kar (net gelir)?

Net kar (net gelir) -112000000.000'dur.

Firmanın toplam borcu nedir?

Toplam borç 145000000.000'dir.

Faaliyet giderleri rakamı nedir?

İşletme giderleri 600100000.000'dır.

Şirket nakit rakamı nedir?

İşletme içi nakit 0.000'tir.